Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
boston
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
startups
blackstone group
clinical trials
david goldstein
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
steven petrou
aligos therapeutics
antisense oligonucleotide
artificial intelligence
azacitidine
baker brothers life sciences
benzodiazepine
benzodiazepines
beta-thalassemia
biogen
biotech ipos
blackstone life sciences
blepharitis
cavion
cephalgia
chronic hepatitis b virus
columbia university
dacogen
What
drugs
4
×
medicines
4
×
research
4
×
new
aims
biotech
called
developing
praxis
precision
algorithms
approach
backed
based
batch
biotechs
bottlenecks
cause
central
ceo
clinical
cns
combinator’s
cost
debuts
development
disorder
dollars
drug
emerged
epigenetic
epigenetics
epilepsy
field
fix
flagship’s
genes
genetic
ipos
kept
Language
unset
Current search:
drugs
×
medicines
×
research
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks